# Hypertonic Modulation of Inflammation Following Injury

> **NCT00750997** · — · TERMINATED · sponsor: **University of Washington** · enrollment: 119 (actual)

## Conditions studied

- Hemorrhagic Shock
- Traumatic Brain Injury

## Interventions

- **DRUG:** hypertonic saline

## Key facts

- **NCT ID:** NCT00750997
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 119 (ACTUAL)
- **Why stopped:** Enrollment in the clinical trial was stopped for futility
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750997, "Hypertonic Modulation of Inflammation Following Injury". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00750997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*